TY - JOUR AU - Schiavetti, B. AU - Wynendaele, E. AU - Melotte, V. AU - Elst, J. AU - Spiegeleer, B. AU - Ravinetto, R. PY - 2020 DA - 2020// TI - A simplified checklist for the visual inspection of finished pharmaceutical products: a way to empower frontline health workers in the fight against poor-quality medicines JO - J Pharm Policy Practice VL - 13 UR - https://doi.org/10.1186/s40545-020-00211-9 DO - 10.1186/s40545-020-00211-9 ID - Schiavetti2020 ER - TY - JOUR AU - Mohamed Ali, G. K. AU - Alfadl, A. A. AU - Fathelrahman, A. I. PY - 2011 DA - 2011// TI - Newspapers’ coverage of contaminated intravenous fluids from an Indian manufacturer distributed by Public Central Medical Supplies in Sudan: lessons to be learned JO - Health Policy. VL - 101 UR - https://doi.org/10.1016/j.healthpol.2010.12.004 DO - 10.1016/j.healthpol.2010.12.004 ID - Mohamed Ali2011 ER - TY - STD TI - Mohamed, G.K. and Ahmed, T.A. NMSF measures to assure the quality of medicines throughout the supply chain. Presented at the International Conference on “Medicine Quality and Public Health”; 23 to 28 September 2018. University of Oxford, Oxford, UK. 2018. Cited 23 July 2020: https://www.tropicalmedicine.ox.ac.uk/events/medicine-quality/mqph2018/speakers. UR - https://www.tropicalmedicine.ox.ac.uk/events/medicine-quality/mqph2018/speakers ID - ref3 ER - TY - STD TI - World Health Organization. Quality assurance of pharmaceuticals: a compendium of guidelines and related materials. Volume 1. 1997. World Health Organization. Geneva. ID - ref4 ER - TY - JOUR AU - Borup, R. AU - Kaae, S. AU - Minssen, T. PY - 2016 DA - 2016// TI - Fighting falsified medicines with paperwork – a historic review of Danish legislation governing distribution of medicines JO - J of Pharm Policy and Pract VL - 9 UR - https://doi.org/10.1186/s40545-016-0078-2 DO - 10.1186/s40545-016-0078-2 ID - Borup2016 ER - TY - STD TI - World Health Organization. (22–31 May 2017). Seventieth World Health Assembly. Annex A70/23. Appendix 3. Geneva, Switzerland. Available: https://www.who.int/medicines/regulation/ssffc/A70_23-en1.pdf?ua=1. Accessed 20 July 2020. UR - https://www.who.int/medicines/regulation/ssffc/A70_23-en1.pdf?ua=1 ID - ref6 ER - TY - JOUR AU - Ravinetto, R. AU - Vandenbergh, D. AU - Macé, C. PY - 2016 DA - 2016// TI - Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy JO - J of Pharm Policy and Pract VL - 9 UR - https://doi.org/10.1186/s40545-016-0088-0 DO - 10.1186/s40545-016-0088-0 ID - Ravinetto2016 ER - TY - JOUR AU - Ravinetto, R. AU - Pinxten, W. AU - Rago, L. PY - 2018 DA - 2018// TI - Quality of medicines in resource-limited settings: need for ethical guidance JO - Global Bioethics VL - 29 UR - https://doi.org/10.1080/11287462.2018.1522991 DO - 10.1080/11287462.2018.1522991 ID - Ravinetto2018 ER - TY - JOUR AU - Orubu, E. S. F. AU - Ching, C. AU - Zaman, M. H. PY - 2020 DA - 2020// TI - Tackling the blind spot of poor-quality medicines in Universal Health Coverage JO - J of Pharm Policy and Pract VL - 13 UR - https://doi.org/10.1186/s40545-020-00208-4 DO - 10.1186/s40545-020-00208-4 ID - Orubu2020 ER - TY - STD TI - Paul N Newton, Katherine C Bond, on behalf of the Oxford Statement signatories. Global access to quality-assured medical products: the Oxford Statement and call to action. Lancet GH 2019: e1609-e1611. ID - ref10 ER - TY - STD TI - NMSF, 2015. Value for money: proposed measures to improve health outcomes from expenditure on medicines and health technologies in Sudan. National Medical Supplies Fund, Khartoum Sudan. Cited 24 July 2020: https://www.researchgate.net/publication/283007568_Value_for_MoneyProposed_Measures_to_Improve_Health_Outcomes_from_Expenditure_on_Medicines_and_Health_Technologies_in_Sudan. UR - https://www.researchgate.net/publication/283007568_Value_for_MoneyProposed_Measures_to_Improve_Health_Outcomes_from_Expenditure_on_Medicines_and_Health_Technologies_in_Sudan ID - ref11 ER - TY - JOUR AU - Gamal, K. M. PY - 2012 DA - 2012// TI - Ali and Abdeen M. Omer. Pharmaceuticals in Sudan: development in regulations, governance and implementation of national drug policies JO - African J Pharmacy Pharmacol VL - 6 UR - https://doi.org/10.5897/AJPP11.023 DO - 10.5897/AJPP11.023 ID - Gamal2012 ER - TY - JOUR AU - Hafner, T. AU - Walkowiak, H. AU - Lee, D. PY - 2017 DA - 2017// TI - et al JO - Defining pharmaceutical systems strengthening: concepts to enable measurement Health Policy and Planning VL - 32 ID - Hafner2017 ER - TY - JOUR AU - Hafner, T. AU - Banda, M. AU - Kohler, J. PY - 2020 DA - 2020// TI - Integrating pharmaceutical systems strengthening in the current global health scenario: three ‘uncomfortable truths’ JO - J of Pharm Policy and Pract VL - 13 UR - https://doi.org/10.1186/s40545-020-00242-2 DO - 10.1186/s40545-020-00242-2 ID - Hafner2020 ER - TY - JOUR AU - Ozawa, S. AU - Higgins, C. R. AU - Yemeke, T. T. AU - Nwokike, J. I. AU - Evans, L. AU - Hajjou, M. PY - 2020 DA - 2020// TI - Importance of medicine quality in achieving universal health coverage JO - PLoS ONE VL - 15 UR - https://doi.org/10.1371/journal.pone.0232966 DO - 10.1371/journal.pone.0232966 ID - Ozawa2020 ER -